{
    "medicine_id": "c95df1c08a63caa0771d68a267d0c9b235c8fd09",
    "platform_id": "DB14712",
    "metadata": {
        "name": "Revcovi 1 6 mg 1mL Injection",
        "composition": "1 6 mg 1mL Elapegademase",
        "clinical_particulars": {
            "therapeutic_indications": "Elapegademase is approved for the treatment of adenosine deaminase severe combined immune deficiency ADA SCID in pediatric and adult patients L4654 This condition was previously treated by the use of bovine pegamedase as part of an enzyme replacement therapy L4655 ADA SCID is a genetically inherited disorder that is very rare and characterized by a deficiency in the adenosine deaminase enzyme The patients suffering from this disease often present with a compromised immune system This condition is characterized by very low levels of white blood cells and immunoglobulin levels which results in severe and recurring infections L4656",
            "contraindications": {
                "disease": "As elapegademase is a therapeutic protein there is a potential risk of immunogenicity There are no studies related to overdose but the highest weekly prescribed dose in clinical trials was 0 4 mg kg In nonclinical studies a dosage of 1 8 fold of the clinical dose produced a slight increase in the activated partial thromboplastin time FDA label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In clinical trials elapegademase was shown to increase adenosine deaminase activity while reducing the concentrations of toxic metabolites which are the hallmark of ADA SCID As well it was shown to improve the total lymphocyte count F1940",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00008",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00019",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegaspargase"
                    },
                    {
                        "drugbank-id": "DB00061",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegademase"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB01839",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Propylene glycol"
                    },
                    {
                        "drugbank-id": "DB03394",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Heptaethylene glycol"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegaptanib"
                    },
                    {
                        "drugbank-id": "DB05202",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Egaptivon pegol"
                    },
                    {
                        "drugbank-id": "DB05321",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with PEG uricase"
                    },
                    {
                        "drugbank-id": "DB05860",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB06022",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with GlycoPEG GCSF"
                    },
                    {
                        "drugbank-id": "DB06293",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegnivacogin"
                    },
                    {
                        "drugbank-id": "DB06325",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegpleranib"
                    },
                    {
                        "drugbank-id": "DB06611",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegsunercept"
                    },
                    {
                        "drugbank-id": "DB06811",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Polidocanol"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginesatide"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Methoxy polyethylene glycol epoetin beta"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09208",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegloticase"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Polyethylene glycol"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Antihemophilic Factor Recombinant PEGylated"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Polyethylene glycol 400"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11661",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Eptacog alfa pegol activated"
                    },
                    {
                        "drugbank-id": "DB11707",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Olaptesed Pegol"
                    },
                    {
                        "drugbank-id": "DB12258",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Abicipar Pegol"
                    },
                    {
                        "drugbank-id": "DB12578",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Lexaptepid Pegol"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12839",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegvaliase"
                    },
                    {
                        "drugbank-id": "DB12842",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegamotecan"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Lipegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Nonacog beta pegol"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Elapegademase can be decreased when used in combination with Damoctocog alfa pegol"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}